Demographic data | CSF pleocytosis group (WBC > 5cells/mm3) | Normocellular CSF group (WBC ≤ 5cells/mm3) |
---|---|---|
Number of patients | 17 | 6 |
Male:female | 9:8 | 1:5 |
Median age (years) [range] | 35 [1–59] | 41 [27–85] |
Underlying disease | ||
Normal | 13 (76.5 %) | 3 (50 %) |
HIV infection | 0 | 1 (16.7 %) |
Diabetes mellitus | 2 (11.8 %) | 0 |
Hematologic malignancy | 2 (11.8 %) | 0 |
Multiple Sclerosis (MS) | 0 | 1 (16.7 %) |
Systemic Lupus Erythematosus (SLE) | 0 | 1 (16.7 %) |
Prodrome | ||
Fever | 1 (5.9 %) | 1 (16.7 %) |
Fever with headache | 9 (52.9 %) | 1 (16.7 %) |
Fever with myalgia | 1 (5.9 %) | 1 (16.7 %) |
Upper respiratory tract symptoms | 1 (5.9 %) | 0 |
Fever with diarrhea | 1 (5.9 %) | 0 |
Fever with non-specific rash | 1 (5.9 %) | 0 |
Headache | 2 (11.8 %) | 0 |
Non-specific | 1 (5.9 %) | 3 (50 %) |
Presenting symptoms | ||
Worsening headache with/without neck stiffness | 2 (11.8 %) | 0 |
Hemiparesis | 1 (5.9 %) | 0 |
Facial weakness | 1 (5.9 %) | 0 |
Severe spastic body and limbs | 1 (5.9 %) | 0 |
Behavioral change and confusion | 4 (23.5 %) | 3 (50 %) |
Seizures | 5 (29.4 %) | 2 (33.3 %) |
Alteration of consciousness | 3 (17.6 %) | 1 (16.7 %) |
Outcome | ||
Complete recovery | 5 (29.4 %) | 1 (16.7 %) |
Partial recovery | 10 (58.8 %) | 4 (66.7 %) |
Dead | 2 (11.8 %) | 1 (16.7 %) |